Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer.

Beth A Hellerstedt1, Kenneth J Pienta

  • 1University of Michigan Medical Center, Ann Arbor, Michigan 48019, USA.

Current Opinion in Oncology
|May 1, 2002
PubMed
Summary
This summary is machine-generated.

Testicular cancer is highly curable, but research continues to improve diagnosis and treatment. New molecular insights and imaging techniques show promise for refining therapies and reducing long-term side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The involvement of cyclin-dependent kinase 7 (CDK7) and 9 (CDK9) in coordinating transcription and cell cycle checkpoint regulation.

Cell cycle (Georgetown, Tex.)·2025
Same author

PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient.

Urology case reports·2025
Same author

Benthic diel oxygen variability and stress as potential drivers for animal diversification in the Neoproterozoic-Palaeozoic.

Nature communications·2025
Same author

Correction to: Urinary extracellular vesicle‑derived miR‑126‑3p predicts lymph node invasion in patients with high‑risk prostate cancer.

Medical oncology (Northwood, London, England)·2025
Same author

Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes.

Molecular & cellular proteomics : MCP·2025
Same author

XeroGraph: enhancing data integrity in the presence of missing values with statistical and predictive analysis.

Bioinformatics advances·2025
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Genetics
  • Medical Imaging

Background:

  • Testicular cancer, while highly curable, still causes mortality in young men.
  • Recent advancements offer new insights into diagnosis, treatment, and prognosis.

Purpose of the Study:

  • To review recent data on testicular cancer diagnosis, treatment, and prognosis.
  • To highlight emerging research in molecular alterations and novel therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on testicular cancer.
  • Focus on genetic and molecular alterations (e.g., i12p, EGFR).
  • Evaluation of current treatment modalities (surgery, platinum-based chemotherapy) and emerging approaches.

Main Results:

Related Experiment Videos

  • Genetic alterations like i12p and EGFR expression are key research areas.
  • Surgery and platinum-based chemotherapy remain primary treatments.
  • Promising research aims to reduce treatment intensity while maintaining cure rates.

Conclusions:

  • Long-term platinum retention and late toxicity require further investigation.
  • Novel tumor markers (e.g., lactate dehydrogenase isoenzyme-1) may improve risk stratification.
  • Positron emission tomography imaging offers potential for reduced surgical intervention and enhanced observation.